Atypical Hemolytic Uremic Syndrome market Forecast. DelveInsight's Atypical Hemolytic Uremic Syndrome Market report offers an in-depth understanding of the ...

Sitala Bio Ltd. has prepared new indole derivatives acting as complement factor B (CFB) inhibitors. They are thus reported to be useful for the treatment of age-related macular degeneration, ...

Eleven people have been sickened in a severe Shiga toxin-producing E. coli (STEC) outbreak in France linked to raw milk cheese. Nine hemolytic ...

Eculizumab biosimilar Elizaria demonstrates long-term safety and efficacy comparable with the reference product Soliris in ...

Soliris (eculizumab) earned $814 million in Q2, up 16% compared to the same period last year, based on its use in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome ...

Inspire Investing LLC decreased its stake in Xencor, Inc. (NASDAQ:XNCR – Free Report) by 14.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...

Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...

After hours: January 29 at 4:08:12 PM EST Loading Chart for XNCR ...

Uremic bleeding syndrome is a recognized consequence of renal failure and can result in clinically significant sequelae. Although the pathophysiology of the condition has yet to be fully ...

The immunologic disorders associated with the development of AtLP include rheumatoid arthritis, Sjögren's syndrome and systemic ... changes in subclones of atypical lymphocytes.

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...